Clinical Trials Logo

Suicide Attempts clinical trials

View clinical trials related to Suicide Attempts.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05796531 Recruiting - Suicidal Ideation Clinical Trials

Therapeutic Evaluative Conditioning to Reduce Adolescents' Self-injurious Thoughts and Behaviors During and After Psychiatric Inpatient Hospitalization

TEC
Start date: March 31, 2023
Phase: N/A
Study type: Interventional

Suicide is the 2nd leading cause of death among adolescents, with the highest risk period for suicide being the month following psychiatric inpatient hospitalization. The investigators propose testing a brief, scalable intervention using evaluative conditioning aimed at reducing suicidal thoughts and behaviors among adolescents during and after inpatient hospitalization. Scalable interventions, such as the one proposed that reduce suicide risk during this markedly high-risk period, could result in large-scale decreases in suicide death.

NCT ID: NCT05078970 Recruiting - Suicidal Ideation Clinical Trials

Advancing Suicide Intervention Strategies for Teens During High Risk Periods

ASSIST
Start date: August 11, 2022
Phase: N/A
Study type: Interventional

To inform the effective management of adolescent suicide risk by evaluating promising treatments and developing the evidence-base for interventions that are well suited for widespread adoption, sustained quality, and impact.

NCT ID: NCT04498143 Recruiting - Clinical trials for Nonsuicidal Self Injury

Single-Session Intervention Targeting Self-Injurious Behavior in Adolescents

Project SAVE
Start date: August 18, 2020
Phase: N/A
Study type: Interventional

Participants (aged 13-16) will be randomized to: (1) an online, active control group program encouraging feelings disclosure (i.e. supportive therapy single session intervention [SSI]), or (2) an online program targeting nonsuicidal self-injury (NSSI; i.e. Project "SAVE"-Stop Adolescent Violence Everywhere-SSI). Investigators will test whether SAVE results in significantly greater: 1. Reductions in NSSI 3 months post-treatment [primary outcome] 2. Reductions in self-reported likelihood of future NSSI immediately post-treatment [secondary outcome] 3. Reduction in suicide ideation frequency 3 months post-treatment [secondary outcome]